Avicanna (AVCN) has successfully exported its CBD-dominant cannabis flower to the first international market through its wholly-owned subsidiary, Rhuena Corporation. This milestone marks a significant step in Avicanna’s strategy to expand its global footprint in the wellness sector.
The shipment consists of over two metric tons of high-quality, CBD-rich flower, which has already received regulatory approval from local authorities in South America. This established regulatory framework in the country facilitates the company’s entry into a growing international market. The exported cannabis flower aims to cater to increasing consumer demand for wellness-focused products containing hemp-derived CBD. This export follows the company’s recent announcement regarding its success in expanding global reach with the first CBD flower export to Switzerland, highlighting its ambitious international strategy.
“Our team has executed the first phase of our international expansion plan by offering premium, CBD-dominant flower and entering a new market,” said Aras Azadian, CEO of Avicanna. “We anticipate this is just the beginning as we look to build strategic partnerships that leverage our expertise in bringing quality products to consumers around the world.”
The global market for CBD products is projected to grow significantly, and Avicanna aims to capitalize on this trend. The company plans to focus on further enhancing its supply chain, research and development capabilities, and product innovation in order to position itself as a leader in the hemp-derived CBD market. According to a recent report on Avicanna’s Q2 2025 performance, the company is strategically positioning itself in the cannabis biopharma sector and aims for long-term value creation.
Avicanna has established itself through a comprehensive, science-driven approach to product development, which includes its proprietary formulations and robust research initiatives. The company’s operations are vertically integrated, from breeding and cultivation to extraction and formulation, ensuring quality and consistency at every stage of the production process.
The export of CBD flower is a part of Avicanna’s broader strategy to increase its market share in response to the rising demand for plant-based wellness products. The company is looking to explore additional international markets and believes that its products can meet the growing consumer interest in natural alternatives, a sentiment reinforced by the establishment of partnerships such as the re+PLAY CBD brand launch in the U.S.
With this successful export, Avicanna is well-positioned to enhance its visibility on a global scale while contributing to the growth of the international cannabinoid sector. The company’s commitment to quality and scientific advancement is expected to drive its future endeavors in the hemp-derived product landscape, reinforcing Avicanna’s intent to become a recognized leader in the global market.
An upward trajectory in demand for CBD products suggests that Avicanna’s robust strategic planning and execution could lead to sustained growth in the ever-evolving cannabinoid industry, per the latest analysis. As the company continues to strengthen its international presence, it aims to fulfill a rising consumer appetite for effective, high-quality wellness solutions.